Mitsubishi Tanabe’s Sales Drop 6.5% in Q1, 5 Billion Yen Loss on Price Cuts

Mitsubishi Tanabe Pharma’s sales fell 6.5% to 91.8 billion yen from a year ago in the first quarter of FY2020, broadly impacted by drug price cuts, according to an earnings report released by its parent Mitsubishi Chemical Holdings on August...read more